GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » E10

Syncom Formulation (India) (NSE:SYNCOMF) E10 : ₹0.25 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Syncom Formulation (India)'s adjusted earnings per share data for the three months ended in Mar. 2024 was ₹0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.25 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Syncom Formulation (India)'s average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-24), Syncom Formulation (India)'s current stock price is ₹13.00. Syncom Formulation (India)'s E10 for the quarter that ended in Mar. 2024 was ₹0.25. Syncom Formulation (India)'s Shiller PE Ratio of today is 52.00.

During the past 13 years, the highest Shiller PE Ratio of Syncom Formulation (India) was 68.21. The lowest was 26.82. And the median was 38.09.


Syncom Formulation (India) E10 Historical Data

The historical data trend for Syncom Formulation (India)'s E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) E10 Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.22 0.25

Syncom Formulation (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.23 0.24 0.25

Competitive Comparison of Syncom Formulation (India)'s E10

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Shiller PE Ratio falls into.



Syncom Formulation (India) E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syncom Formulation (India)'s adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.09/153.0345*153.0345
=0.090

Current CPI (Mar. 2024) = 153.0345.

Syncom Formulation (India) Quarterly Data

per share eps CPI Adj_EPS
201312 0.040 91.425 0.067
201403 0.033 91.425 0.055
201406 0.020 94.103 0.033
201409 0.040 96.780 0.063
201412 0.040 96.780 0.063
201503 0.025 97.163 0.039
201506 0.030 99.841 0.046
201509 0.040 101.753 0.060
201512 0.030 102.901 0.045
201603 0.033 102.518 0.049
201606 0.030 105.961 0.043
201703 0.030 105.196 0.044
201706 0.030 107.109 0.043
201709 0.030 109.021 0.042
201712 0.050 109.404 0.070
201803 0.010 109.786 0.014
201806 0.026 111.317 0.036
201809 0.040 115.142 0.053
201812 0.050 115.142 0.066
201903 0.030 118.202 0.039
201906 0.038 120.880 0.048
201909 0.050 123.175 0.062
201912 0.040 126.235 0.048
202003 0.040 124.705 0.049
202006 0.040 127.000 0.048
202009 0.120 130.118 0.141
202012 0.130 130.889 0.152
202103 0.071 131.771 0.082
202106 0.070 134.084 0.080
202109 0.060 135.847 0.068
202112 0.060 138.161 0.066
202203 0.050 138.822 0.055
202206 0.030 142.347 0.032
202209 0.060 144.661 0.063
202212 0.060 145.763 0.063
202303 0.100 146.865 0.104
202306 0.070 150.280 0.071
202309 0.080 151.492 0.081
202312 0.090 152.924 0.090
202403 0.090 153.035 0.090

Add all the adjusted EPS together and divide 10 will get our e10.


Syncom Formulation (India)  (NSE:SYNCOMF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Syncom Formulation (India)'s Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=13.00/0.25
=52.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Syncom Formulation (India) was 68.21. The lowest was 26.82. And the median was 38.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Syncom Formulation (India) E10 Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines